Results 161 to 170 of about 171,882 (296)

Long‐Term Outcomes of Reduced‐Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function

Arthritis &Rheumatology, EarlyView.
Objective High‐intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced systemic sclerosis (SSc). The role of reduced‐intensity conditioning (RIC) before AHSCT in this population remains unclear.
Yonatan Lean, Carrie Richardson, Anthony J. Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

Gender differences in clinical profiles, management and outcomes of valvular heart disease in China: insights from a nationwide cohort. [PDF]

BMJ Open
Ma H, Lu Q, Li Z, Ye Y, Zhang B, Wang W, Liu Q, Lv J, Zhao Z, Duan Z, Wang B, Yu Z, Guo S, Zhao Y, Gao R, Wu Y, Xu H.   +16 more
europepmc   +1 more source

TWEAK/Fn14 signaling drives oxidative cardiac injury in systemic lupus erythematosus: Evidence from patient biomarker studies, lupus mouse models, and cardiomyocyte assays

Arthritis &Rheumatology, Accepted Article.
Objective Cardiac involvement is a major cause of morbidity in systemic lupus erythematosus (SLE). Tumor necrosis factor–like weak inducer of apoptosis (TWEAK) is elevated in SLE, but its contribution to lupus‐associated cardiac injury is unclear. We investigated the role of TWEAK/Fn14 signaling in SLE‐related cardiomyopathy and its potential as a ...
Yale Liu, Zhu Yan, Xueting Peng, Meixuan Li, Juan Wang, Yan Zhang, Xiaoqian Hu, Mingzhu Zhou, Kaixuan Ren, Dan Zhang, Xingyi Guo, Yumin Xia, Huanhuan Huo   +12 more
wiley   +1 more source

Radiation-Induced Valvular Heart Disease: A Narrative Review of Epidemiology, Diagnosis and Management. [PDF]

J Cardiovasc Dev Dis
Varvara AM, Parasca CA, Iliescu VA, Jurcuț RO.   +3 more
europepmc   +1 more source

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

British Journal of Clinical Pharmacology, EarlyView.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse, Christophe Hommel, Nadine Petitpain, Philippe Kerschen   +3 more
wiley   +1 more source

The Valvular Heart Disease-specific Age-adjusted Comorbidity Index (VHD-ACI) score in patients with moderate or severe valvular heart disease. [PDF]

J Geriatr Cardiol
Xie MR, Zhang B, Ye YQ, Li Z, Liu QR, Zhao ZY, Lv JX, Feng DJ, Zhao QH, Zhang HT, Duan ZY, Wang BC, Guo S, Zhao YY, Gao RL, Xu HY, Wu YJ.   +16 more
europepmc   +1 more source

Macrophage‐targeted cerium‐tannic acid metal‐polyphenol framework nanoenzyme promotes in situ heart valves regeneration through adaptive immunomodulation

BMEMat, EarlyView.
A novel nanoenzyme based on cerium ions‐tannic acid metal‐polyphenol framework (FCT) has been developed and loaded onto DHVs for targeting M1 macrophages to reduce their ROS level and reprogram macrophage phenotype, thereby eliminating inflammation, promoting endothelialization and adaptive matrix remodeling of scaffolds, offering a promising strategy ...
Peng Song, Yunlong Wu, Xing Chen, Yafei Liu, Mengna Dong, Jiawei Shi, Xichi Wang, Nianguo Dong, Weihua Qiao, Qin Wang   +9 more
wiley   +1 more source

Coronary Artery Disease in Patients With Valvular Heart Disease. [PDF]

JACC Asia
Fong FK, So KC.
europepmc   +1 more source

Extremity Function After Transfemoral Transcatheter Aortic Valve Implantation: A TAVI XS Sub‐Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Physical decline after transcatheter aortic valve implantation (TAVI) is associated with worse outcomes. However, data on post‐TAVI extremity function are limited. This sub‐study of the TAVI XS trial aimed to assess extremity function after transfemoral TAVI, evaluate functional decline, compare outcomes between upper‐and lower ...
Geert A. A. Versteeg, Maxim J. P. Rooijakkers, Kimberley I. Hemelrijk, Pieter J. Vlaar, Daniël C. Overduin, Marleen H. van Wely, Hugo M. Aarts, Dirk‐Jan van Ginkel, Niels A. Stens, Lokien X. van Nunen, Robert Jan van Geuns, Leen A. F. M. van Garsse, Guillaume S. C. Geuzebroek, Michel W. A. Verkroost, Aysun Cetinyurek‐Yavuz, Robin H. Heijmen, Dick H. J. Thijssen, Jurrien M. ten Berg, Pim A. L. Tonino, Ronak Delewi, Niels van Royen   +20 more
wiley   +1 more source

Pan-valvular heart disease in a dialysis patient with progressive jaundice: case report. [PDF]

Eur Heart J Case Rep
Chang CC, Tseng CH, Lee CW, Sung SH.
europepmc   +1 more source